GERN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Geron Corp (GERN) is not a strong buy at this time for a beginner investor with a long-term strategy. The stock is underperforming in the short term, with negative price momentum and missed financial expectations. While hedge funds are increasing their positions, the company's profitability challenges and lack of strong positive catalysts make it more prudent to hold off on investing until clearer signs of growth or stability emerge.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 40.863, and the stock is trading below its pivot level of 1.78, suggesting resistance to upward movement. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the overall trend remains weak with significant price declines in recent trading sessions.
Hedge funds have increased their buying activity by 226.92% over the last quarter, indicating institutional interest. RYTELO sales grew by 9% QoQ, and the company projects higher revenue for 2026.
The company missed Q4 2025 earnings and revenue expectations, with a widening net loss. Operating expenses remain high, and gross margin declined YoY. Analyst Tara Bancroft lowered the price target from $4 to $3, reflecting reduced confidence. The stock has shown consistent negative price performance in recent sessions.
In Q4 2025, revenue increased slightly by 1.01% YoY to $48 million, but net income remained negative at -$31.14 million, albeit improving by 22.85% YoY. EPS also improved to -$0.05, up 25% YoY. However, gross margin dropped to 97.28%, down -1.09% YoY, indicating profitability challenges.
Analyst Tara Bancroft from TD Cowen maintains a Buy rating but lowered the price target from $4 to $3, reflecting cautious optimism. Analysts remain optimistic about long-term potential but are concerned about short-term performance.
